Kopran is currently trading at Rs. 265.95, up by 3.70 points or 1.41% from its previous closing of Rs. 262.25 on the BSE.
The scrip opened at Rs. 260.00 and has touched a high and low of Rs. 271.00 and Rs. 260.00 respectively. So far 50938 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 292.40 on 08-Feb-2024 and a 52 week low of Rs. 160.00 on 11-Aug-2023.
Last one week high and low of the scrip stood at Rs. 271.00 and Rs. 247.45 respectively. The current market cap of the company is Rs. 1281.68 crore.
The promoters holding in the company stood at 44.49%, while Institutions and Non-Institutions held 0.82% and 54.70% respectively.
Kopran’s subsidiary -- Kopran Research Laboratories has received Environmental Clearance from Government of India - Ministry of Environment, Forest and Climate Change on July 30, 2024 for Manufacturing of Synthetic Organic Chemicals (Active Pharmaceutical Ingredients and its Intermediates) up to 97 MTs/Month at its Manufacturing Unit at GIDC Panoli, Taluka: Ankleshwar, District: Bharuch, Gujrat.
The company will now obtain Consent to Establish (CTE) and Consent to Operate (CCA) from Gujarat Pollution Control Board for additional capacities approval under the Environmental Clearance received.
Kopran is engaged primarily in pharmaceuticals business. The Company manufactures both Active Pharmaceutical Ingredients and Finished Dosage Forms.
